New pill aims to tame Narcolepsy's sudden sleep attacks
NCT ID NCT07455383
Summary
This study is testing whether a new tablet called ALKS 2680 can help adults with narcolepsy type 1 stay awake during the day and reduce sudden muscle weakness (cataplexy). About 150 participants will take either the study drug or a placebo (inactive pill) for 12 weeks to see which works better. The main goal is to see if the drug improves the ability to stay awake and reduces key symptoms of the condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NARCOLEPSY TYPE 1 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.